Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

170.16
-2.8300-1.64%
Post-market: 169.94-0.2230-0.13%19:58 EDT
Volume:7.36M
Turnover:1.26B
Market Cap:301.01B
PE:71.20
High:174.17
Open:173.47
Low:168.54
Close:172.99
Loading ...

Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

Zacks
·
08 Apr

AbbVie Gets Expanded Europe OK for Rinvoq in Giant Cell Arteritis

Dow Jones
·
08 Apr

AbbVie assumed with a Neutral at Goldman Sachs

TIPRANKS
·
08 Apr

AbbVie Secures European Marketing Clearance for Giant Cell Arteritis Treatment Rinvoq

MT Newswires Live
·
08 Apr

BRIEF-Abbvie Announces European Commission Approval Of Rinvoq For Adults

Reuters
·
08 Apr

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis

PR Newswire
·
08 Apr

AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting

Simply Wall St.
·
08 Apr

Tariffs Pose $46 Billion Risk to Pharmaceutical Industry -- Analysis

Dow Jones
·
05 Apr

Shares of Some U.S. Drugmakers Down After Trump Says Pharmaceutical Sector Is 'Under Review' for Tariffs

THOMSON REUTERS
·
04 Apr

BUZZ-US drugmakers fall after Trump's new tariff warnings

Reuters
·
04 Apr

AbbVie (ABBV) Stock Moves -1.73%: What You Should Know

Zacks
·
04 Apr

AbbVie Issues Q1 Adjusted Earnings Outlook, Cuts Full-Year Guidance

MT Newswires Live
·
04 Apr

AbbVie cuts 2025 profit forecast on acquisition expenses

Reuters
·
04 Apr

BRIEF-Abbvie Inc - Q1 2025 Earnings Include $248 Million Ipr&D And Milestones Expense - SEC Filing

Reuters
·
04 Apr

Abbvie Inc - Q1 2025 Adjusted EPS Guidance $2.34 - $2.38 - SEC Filing

THOMSON REUTERS
·
04 Apr

Abbvie Inc - Q1 2025 Earnings Include $248 Million Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS
·
04 Apr

Abbvie Inc Q1 Shr View $2.51 -- Lseg Ibes Data

THOMSON REUTERS
·
04 Apr

Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath

Dow Jones
·
04 Apr

BUZZ-US drugmakers rise on reprieve from Trump tariffs

Reuters
·
03 Apr

Shares of US Drugmakers Rise After Tariff Exemption

THOMSON REUTERS
·
03 Apr